---
id: marburg-ebola-viruses_312
category: organisms
tags: [Marburg-virus, Ebola-virus, filovirus, viral-hemorrhagic-fever, fruit-bats, Africa, outbreak]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Marburg and Ebola Virus Diseases

**Q:** What are the key features, mortality rates, and clinical phases of Marburg and Ebola virus diseases?

**A:**

**Overview:**
- **Family**: Filoviridae (filoviruses)
- **Reservoir**: *Rousettus aegyptiacus* **fruit bats**
- **Transmission**: Fruit bat exposure → human-to-human via **body fluids** (blood, vomit, feces, urine, saliva, sweat)
- Clinically similar hemorrhagic fevers

**Epidemiology:**

**Recent Outbreaks:**
- **Rwanda (2024)**: First outbreak - 66 cases, 15 deaths (**23% CFR**)
- **Tanzania (January 2025)**: Kagera region outbreak

**Mortality:**
- **Marburg**: **24-88% CFR** (average **~50%**)
- **Ebola**: Variable by species; Zaire ebolavirus **~50-90%**

**Clinical Phases (Marburg - similar for Ebola):**

**Incubation:** **2-21 days**

| Days Post-Onset | Clinical Features |
|-----------------|-------------------|
| **1-3** | **Abrupt high fever**, severe headache, severe malaise, myalgia; **GI symptoms by day 3** (watery diarrhea, abdominal pain, nausea, vomiting) |
| **2-7** | **Non-itchy maculopapular rash** (trunk → extremities) |
| **≥5** | **Hemorrhagic manifestations**: Bleeding from mucous membranes (nose, gums, eyes), blood in vomit/urine/stool, conjunctival hemorrhage |
| **Late** | Orchitis, CNS involvement (confusion, aggression) |
| **Fatal cases** | Death **8-9 days** after symptom onset |

**Diagnosis:**
- RT-PCR (acute phase)
- Antibody-capture ELISA
- Antigen-capture detection
- Virus isolation (BSL-4 lab)

**Treatment:**
- **NO approved vaccines or antivirals** for Marburg
- **Supportive care**: Rehydration, symptom management (improves survival)
- Experimental monoclonal antibodies and antivirals under evaluation

**Infection Control:**
- **Standard + enhanced PPE** (contact with body fluids/contaminated surfaces)
- **Isolation** of suspected/confirmed cases
- Safe burial practices

**Key Points:**
- Both cause **viral hemorrhagic fever** (bleeding from multiple orifices)
- **Fruit bats** natural reservoir
- High mortality (24-88% Marburg; 50-90% Ebola)
- **Human-to-human transmission** via body fluids
- Death typically **8-9 days** after onset (fatal cases)

**Mnemonic - "Fruit bats Bleed Bodily Fluids"**: Fruit bats reservoir, hemorrhagic manifestations (bleeding), transmission via body fluids

**Pearl:** Marburg and Ebola are clinically similar filovirus hemorrhagic fevers with 24-88% mortality. Fruit bats are natural reservoirs. NO approved antivirals—supportive care is critical. Recent 2024 Rwanda outbreak had lower CFR (23%) with aggressive supportive care.

**Media:**

**Sources:** [WHO Marburg Fact Sheet 2024], [CIDRAP Rwanda Marburg Outbreak], [PMC12053247 - Marburg Narrative Review], [CFSPH Filovirus Factsheet]
